Abcam appoints Cheri Walker, PhD, as Senior Vice President, Corporate Development

Cambridge, UK – 30 October 2018: Abcam plc, a global innovator in life science reagents and tools, announced today that it has appointed Cheri Walker, PhD, to the role of Senior Vice President, Corporate Development.

Cheri is an accomplished industry professional with over 20 years’ experience in the life sciences tools and diagnostics sector. She previously held the role of Chief Financial Officer and SVP, Corporate Development at Kailos Genetics where she was responsible for the strategic growth and expansion of the company. Prior to joining Kailos Genetics, Cheri held senior level corporate development roles at Invitrogen, QIAGEN and Charles River Laboratories.

Cheri has a PhD from Baylor College of Medicine in Human and Molecular Genetics and a BA in Biology from Swarthmore College.

Based in Abcam’s Boston, MA, (USA) office, Cheri will oversee acquisitions and partnerships and shape the company’s corporate development strategy.

“We are delighted to welcome Cheri to the team. Cheri brings a wealth of scientific and corporate development experience to the role. Her appointment will strengthen Abcam’s leadership team and will help focus our future acquisition and partnership opportunities to achieve continued growth”.

– Alan Hirzel, CEO, Abcam